47
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Pathogenic Neisseria meningitidis utilizes CD147 for vascular colonization

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Neisseria meningitidis is the causative agent of potentially fatal meningitis and septic shock, induced by bacterial colonization of blood vessels in the brain and the periphery. The endothelial cell receptor mediating meningococcal adhesion to blood vessels has previously been unknown. Here Sandrine Bourdoulous and colleagues report that CD147 expressed on human endothelial cells is a crucial mediator of N. meningitidis vascular colonization, providing new insight into some of the mechanisms that give rise to meningococcal disease.

          Supplementary information

          The online version of this article (doi:10.1038/nm.3563) contains supplementary material, which is available to authorized users.

          Abstract

          Neisseria meningitidis is a cause of meningitis epidemics worldwide and of rapidly progressing fatal septic shock. A crucial step in the pathogenesis of invasive meningococcal infections is the adhesion of bloodborne meningococci to both peripheral and brain endothelia, leading to major vascular dysfunction. Initial adhesion of pathogenic strains to endothelial cells relies on meningococcal type IV pili, but the endothelial receptor for bacterial adhesion remains unknown. Here, we report that the immunoglobulin superfamily member CD147 (also called extracellular matrix metalloproteinase inducer (EMMPRIN) or Basigin) is a critical host receptor for the meningococcal pilus components PilE and PilV. Interfering with this interaction potently inhibited the primary attachment of meningococci to human endothelial cells in vitro and prevented colonization of vessels in human brain tissue explants ex vivo and in humanized mice in vivo. These findings establish the molecular events by which meningococci target human endothelia, and they open new perspectives for treatment and prevention of meningococcus-induced vascular dysfunctions.

          Supplementary information

          The online version of this article (doi:10.1038/nm.3563) contains supplementary material, which is available to authorized users.

          Related collections

          Most cited references59

          • Record: found
          • Abstract: found
          • Article: not found

          Epidemic meningitis, meningococcaemia, and Neisseria meningitidis.

          Meningococcus, an obligate human bacterial pathogen, remains a worldwide and devastating cause of epidemic meningitis and sepsis. However, advances have been made in our understanding of meningococcal biology and pathogenesis, global epidemiology, transmission and carriage, host susceptibility, pathophysiology, and clinical presentations. Approaches to diagnosis, treatment, and chemoprophylaxis are now in use on the basis of these advances. Importantly, the next generation of meningococcal conjugate vaccines for serogroups A, C, Y, W-135, and broadly effective serogroup B vaccines are on the horizon, which could eliminate the organism as a major threat to human health in industrialised countries in the next decade. The crucial challenge will be effective introduction of new meningococcal vaccines into developing countries, especially in sub-Saharan Africa, where they are urgently needed.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Complete genome sequence of Neisseria meningitidis serogroup B strain MC58.

            The 2,272,351-base pair genome of Neisseria meningitidis strain MC58 (serogroup B), a causative agent of meningitis and septicemia, contains 2158 predicted coding regions, 1158 (53.7%) of which were assigned a biological role. Three major islands of horizontal DNA transfer were identified; two of these contain genes encoding proteins involved in pathogenicity, and the third island contains coding sequences only for hypothetical proteins. Insights into the commensal and virulence behavior of N. meningitidis can be gleaned from the genome, in which sequences for structural proteins of the pilus are clustered and several coding regions unique to serogroup B capsular polysaccharide synthesis can be identified. Finally, N. meningitidis contains more genes that undergo phase variation than any pathogen studied to date, a mechanism that controls their expression and contributes to the evasion of the host immune system.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              The hCMEC/D3 cell line as a model of the human blood brain barrier

              Since the first attempts in the 1970s to isolate cerebral microvessel endothelial cells (CECs) in order to model the blood–brain barrier (BBB) in vitro, the need for a human BBB model that closely mimics the in vivo phenotype and is reproducible and easy to grow, has been widely recognized by cerebrovascular researchers in both academia and industry. While primary human CECs would ideally be the model of choice, the paucity of available fresh human cerebral tissue makes wide-scale studies impractical. The brain microvascular endothelial cell line hCMEC/D3 represents one such model of the human BBB that can be easily grown and is amenable to cellular and molecular studies on pathological and drug transport mechanisms with relevance to the central nervous system (CNS). Indeed, since the development of this cell line in 2005 over 100 studies on different aspects of cerebral endothelial biology and pharmacology have been published. Here we review the suitability of this cell line as a human BBB model for pathogenic and drug transport studies and we critically consider its advantages and limitations.
                Bookmark

                Author and article information

                Contributors
                sandrine.bourdoulous@inserm.fr
                Journal
                Nat Med
                Nat. Med
                Nature Medicine
                Nature Publishing Group US (New York )
                1078-8956
                1546-170X
                1 June 2014
                2014
                : 20
                : 7
                : 725-731
                Affiliations
                [1 ]GRID grid.462098.1, ISNI 0000 0004 0643 431X, INSERM, U1016, Institut Cochin, ; Paris, France
                [2 ]GRID grid.462098.1, ISNI 0000 0004 0643 431X, CNRS, UMR8104, ; Paris, France
                [3 ]GRID grid.10992.33, ISNI 0000 0001 2188 0914, Université Paris Descartes, Sorbonne Paris Cité, ; Paris, France
                [4 ]GRID grid.7452.4, ISNI 0000 0001 2217 0017, Université Paris Diderot, ; Paris, France
                [5 ]GRID grid.465541.7, INSERM, U1151, Institut Necker Enfants Malades, ; Paris, France
                [6 ]GRID grid.4444.0, ISNI 0000 0001 2112 9282, CNRS, UMR8253, ; Paris, France
                [7 ]GRID grid.10992.33, ISNI 0000 0001 2188 0914, Faculté de Médecine, Université Paris Descartes, Sorbonne Paris Cité, ; Paris, France
                [8 ]GRID grid.412134.1, ISNI 0000 0004 0593 9113, Assistance Publique–Hôpitaux de Paris, Hôpital Necker Enfants Malades, ; Paris, France
                [9 ]GRID grid.428999.7, ISNI 0000 0001 2353 6535, Unité Histopathologie Humaine et Modèles Animaux, Institut Pasteur, ; Paris, France
                [10 ]GRID grid.12832.3a, ISNI 0000 0001 2323 0229, Faculté de Médecine, Université Versailles Saint-Quentin-en-Yvelines, ; Versailles, France
                [11 ]GRID grid.50550.35, ISNI 0000 0001 2175 4109, Assistance Publique–Hôpitaux de Paris, Hôpital Raymond Poincaré, ; Paris, France
                [12 ]GRID grid.412041.2, ISNI 0000 0001 2106 639X, BMYscreen, INSERM U1053, Université de Bordeaux, ; Bordeaux, France
                [13 ]GRID grid.463727.3, ISNI 0000 0004 0386 3856, Cellular Microbiology of Infectious Pathogens, Center for Infection and Immunity of Lille, Institut Pasteur de Lille, ; Lille, France
                [14 ]CNRS UM8204, Lille, France
                [15 ]GRID grid.8970.6, ISNI 0000 0001 2159 9858, INSERM U1019, ; Lille, France
                [16 ]GRID grid.412304.0, ISNI 0000 0004 1759 9865, BioImaging Center Lille (BICeL), Université Lille Nord de France, ; Lille, France
                [17 ]GRID grid.83440.3b, ISNI 0000000121901201, Present Address: Present address: Research Department of Infection, University College London, London, UK., ; ,
                Article
                BFnm3563
                10.1038/nm.3563
                7095922
                24880614
                f470f239-9463-43cc-9487-5a04e77a9dce
                © Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. 2014

                This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.

                History
                : 10 February 2014
                : 10 April 2014
                Categories
                Article
                Custom metadata
                © The Author(s), under exclusive licence to Springer Nature America, Inc. 2014

                Medicine
                meningitis
                Medicine
                meningitis

                Comments

                Comment on this article